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A B S T R A C T
Acetylcholinesterase (AChE) from Electrophorus electricus (eel) was immobilized on the surface of amino-modiﬁed
paramagnetic beads to serve as a model for the development, validation and application of a new aﬃnity-based
ligand-ﬁshing assay for the discovery of bioactive peptides from complex protein mixtures such as venoms. Nano
liquid chromatography-mass spectrometry (nanoLC-MS) was used for the analysis of trapped peptides. Using
enzyme-functionalized beads, the ligand-ﬁshing assay was evaluated and optimized using a peptide reference
mixture composed of one acetylcholinesterase binder (fasciculin-II) and ﬁve non-binders (mambalgin-1, an-
giotensin-II, bradykinin, cardiotoxin and α-bungarotoxin). As proof of concept, snake venom samples spiked
with fasciculin-II demonstrated assay selectivity and sensitivity, ﬁshing the peptide binder from complex venom
solutions at concentrations as low as 1.0 μg/mL. As negative controls for method validation, venoms of four
diﬀerent snake species, not known to harbor AChE binding peptides, were screened and no AChE binders were
detected. The applicability of the ligand ﬁshing assay was subsequently demonstrated with venom from the
black mamba, Jameson's mamba and western green mamba (Dendroaspis spp.), which have previously been
reported to contain the AChE binding fasciculins. Unknown peptides (i.e. not fasciculins) with aﬃnity to AChE
were recovered from all mamba venoms tested. Tryptic digestion followed by nano-LC-MS analysis of the ma-
terial recovered from black mamba venom identiﬁed the peptide with highest AChE-binding aﬃnity as den-
drotoxin-I, a pre-synaptic neurotoxin previously not known to interact with AChE. Co-incubation of AChE with
various dendrotoxins in vitro revealed reduced inactivation of AChE activity over time, thus demonstrating that
these toxins stabilize AChE.
1. Introduction
The large biomolecular diversity observed in nature is the result of
billions of years of evolution that has resulted in enormous numbers of
secondary metabolites in plants, microorganisms and animals (Berkov
et al., 2014). Many of these compounds have had their biological ac-
tivities characterized, and some exhibit medicinal potential. Modern
medicinal chemistry originated in the 20th century with the use of
plant-derived structures as templates to synthesize derivatives. Ad-
vances in biotechnology enabled microorganisms to be grown more
eﬃciently and allowed further advances in eﬃcient, large-scale pro-
duction and isolation of biologically active compounds of interest.
During the last few decades, venoms have gained considerable in-
terest as sources of compounds for drug discovery (King, 2011, 2015).
In contrast to small secondary metabolites as the starting point for drug
discovery, venomous animals produce mainly peptide and protein
toxins. These peptides/proteins are highly selective and act potently on
their targets. As these targets are often drug targets, venom components
encompass interesting candidates for drug discovery (Harvey, 2014;
King, 2011; Norton, 2017; Saez et al., 2010). Although venoms are a
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rich source for ﬁnding new bioactive compounds for drug discovery,
maintaining the biological activity of the peptides or proteins during
isolation is a challenge. Furthermore, venoms are highly bioactive,
complex mixtures with many diﬀerent (often interfering) bioactivities.
Therefore the identiﬁcation of desired bioactives in the presence of
many other compounds makes venom-based drug discovery a challen-
ging process. Nonetheless, advances in analytical chemistry have re-
sulted in current state-of-the-art analytics allowing separation and
puriﬁcation of many types of venom peptides/proteins in their active
form for assessment as potential bioactives that act on selected drug
targets (Koh and Kini, 2012).
The majority of described animal toxins that exhibit properties
amenable to medical and biochemical applications exert cardiovascular
and/or neuroactive properties (Jumblatt et al., 1981; Koh and Kini,
2012; Miljanich, 2004; Monge-Fuentes et al., 2012). An example of a
successful drug derived from venom is exenatide, a 39 amino acid
peptide from Heloderma suspectum (the Gila monster - a venomous li-
zard) that was approved by the FDA for treatment of type 2 diabetes
(Berkov et al., 2014; Harvey, 2014), and also shows potential for the
management of Parkinson's disease (Athauda et al., 2017). Other ex-
amples of notable successes in this area have resulted from research on
snake venoms from the vipers Bothrops jararaca, Sistrurus miliarius
barbouri and Echis carinatus, resulting in the clinical peptide-based
medicines captopril, eptiﬁbatide and tiroﬁban (King and Hardy, 2013).
The generic process involved in screening complex mixtures such as
venoms usually involves bioactivity-guided separations and ﬁngerprint
chromatogram analysis; both time-consuming and high cost meth-
odologies (Qing et al., 2011; Weller, 2012; Zhu et al., 2015). Hence the
research community is constantly seeking to increase the range and
scope of analytical screening strategies (Kool et al., 2011b; Vetter et al.,
2015).
Recent advances in separation science and detection technologies
have fueled research into adjusted, advanced and/or new bioactivity
screening formats for venom proﬁling. High-resolution screening, for
example, uses a continuous ﬂow bioassay that is coupled directly on-
line after a liquid chromatographic (LC) separation with mass spec-
trometry (MS) in parallel. This way, the direct characterization of
bioactive compounds identiﬁed in the bioassay is possible (Iyer et al.,
2016; Kool et al., 2011a; Otvos et al., 2013). Other aﬃnity-based
screening assays for complex mixture analysis are pre-column and on-
column based (Cieśla and Moaddel, 2016; Jonker et al., 2011; Moaddel
and Wainer, 2009). A very straightforward approach is the use of oﬀ-
line ligand-ﬁshing assays (Marszałł et al., 2008; Moaddel et al., 2007;
Oujji et al., 2012; Pochet et al., 2011; Wubshet et al., 2015; Yasuda
et al., 2011). In this technique, target-coated beads are immersed di-
rectly into the natural extracts under study. Compounds with aﬃnity
for the immobilized target will be retained while non-binders will re-
main in solution. The bound compounds can then be eluted to identify
them using LC-MS (Hu et al., 2008; Marszałł et al., 2008; Moaddel et al.,
2007; Oujji et al., 2012; Vanzolini et al., 2013; Yasuda et al., 2011). The
principle of ligand ﬁshing is well known, and is established in the area
of immuno-precipitation assays, but it is relatively unexplored as a
technique for identifying peptide and protein ligands. In this regard, the
technique can be valuable for venom proﬁling. As many venoms con-
tain a multitude of proteases and other enzymes, ﬁrst the potential ef-
fects of these components must be evaluated and assay conditions have
to be optimized and validated for screening purposes.
Herein we report a new label-free aﬃnity screening assay based on
paramagnetic beads with immobilized acetylcholinesterase (AChE) for
identifying AChE ligands from venoms. The only known AChE-binding
venom peptides are potent (for mammalian AChEs) inhibitors known as
fasciculins (belonging to the three ﬁnger toxin family [3FTx]), pri-
marily found in venom of the eastern green mamba, Dendroaspis an-
gusticeps (Karlsson et al., 1984). However, literature also demonstrates
that fasciculin aﬃnity for eelAChE is much lower in comparison to
AChEs from mouse or human erythrocytes (Gonicnik and Stojan, 2002).
Evaluation and development of our AChE-aﬃnity ﬁshing method was
started using a reference peptide mixture containing one known AChE
binder and several assumed non-binders. After assay development and
validation, as a proof of concept, Naja pallida (red spitting cobra)
venom was spiked with a known AChE binder, fasciculin II, and sub-
sequently analyzed. Following this, we assessed venoms sourced from
various elapid and viperid snake genera (Dendroaspis, Aspidelaps, Mi-
crurus, Vipera and Crotalus), of which some (e.g. Dendroapsis spp. – the
mambas) were expected to contain AChE inhibitors (i.e. fasciculins).
2. Experimental section
2.1. Materials
The peptides angiotensin II, bradykinin, cardiotoxin and AChE from
Electrophorus electricus type VI-S (eelAChE), together with chemicals
used for the enzyme immobilization procedure and tryptic digestion,
and snake venoms from Naja pallida and Vipera ammodytes were all
purchased from Sigma-Aldrich. Crotalus basiliscus venom was from
Ventoxin (USA), Aspidelaps scutatus scutatus venom was from African
Reptiles & Venoms (Johannesburg, South Africa) and Micrurus ni-
grocinctus venom was from Medtoxin Venom Laboratories (DeLand,
Florida, USA). Mamba venoms (Dendroaspis spp.) were collected from
snakes housed and maintained in the Alistair Reid Venom Research
Unit herpetarium at the Liverpool School of Tropical Medicine (UK).
Following collection, venoms were lyophilized and stored at 4 °C until
reconstitution. Fasciculin II, α-dendrotoxin and δ-dendrotoxin, all iso-
lated from D. angusticeps venom, and dendrotoxin I and dendrotoxin-K,
both isolated from D. polylepis venom, was purchased from Alomone
Labs (Israel). α-bungarotoxin was purchased from Tocris (Bio-techne,
UK) and mambalgin-1 was donated by Smartox Biotechnology (France).
Tacrine hydrochloride was purchased from Sigma-Aldrich. BcMag™
amine-terminated magnetic beads (MB) were from Bioclone (USA).
Trypsin gold, MS-grade (Promega) was used in the digestion assays.
Methanol and acetonitrile (ACN) were MS grade (Biosolve Chimie,
France) and Milli-Q water (Merck Millipore) was used for all experi-
ments.
2.2. Mamba venom proteomics analysis
The tryptic digestion protocol was based on that described in the
supplier's instructions (Promega). Brieﬂy, dithiothreitol (DTT) was used
as reductant and iodoacetamide (IDA) as alkylation agent. Venom
(30 μL of a 140 μg/mL solution prepared in 50mM ammonium bi-
carbonate) was added to a 1.5ml microcentrifuge tube and heated for
10min at 40 °C. Next, DTT (7.5 μL of 100mM solution in 50mM am-
monium bicarbonate) was added and the tube heated to 95 °C for
10min. After cooling to room temperature, IDA (3.7 μL of 100mM
solution in 50mM ammonium bicarbonate) was added to the mixture
and the tube was placed in the dark for 20min. 1.0 μL of trypsin so-
lution (1.0 μg/mL) was then added and the mixture was left at 37 °C
overnight. Formic acid (0.1% in 57.8 μL of Milli-Q water) was ﬁnally
added to each digested sample, resulting in a ﬁnal volume of 100 μL.
The samples were then transferred to chromatography vials and 1.0 μL
analyzed using nanoLC-MS.
2.3. Chromatography system and conditions
An UltiMate™ 3000 UHPLC+ nano system (Thermo Scientiﬁc) was
used in all chromatography separations with an analytical capillary
column (Acclaim® PepMap RSLC C18, 75 μm×15 cm, 2 μm, 100 Å) and,
a nano-trap column Acclaim PepMap100 C18 (100 μm×2 cm, 5 μm,
100 Å). For the analytical capillary column, the ﬂow rate used was
500 nLmin−1, with the mobile phase consisting of 0.1% FA in water
(solvent A) and ACN:water (80:20, v/v, 0.1% FA) (solvent B). In the
nano-trap column, the solvent used was ACN:water (1:99 (v/v), 0.05%
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triﬂuoroacetic acid). The nanoLC system was coupled to an ESI-qTOF
mass spectrometer (Impact HD, equipped with an Advance
CaptiveSpray Source, Bruker Daltonics). The Captive® spray source
conditions were: 1300 V for the capillary voltage, 0.2 bar for the
nebulizer gas (N2) pressure, 3.0 Lmin−1 and 150 °C for the dry gas (N2)
ﬂow rate and temperature. The analyses were performed in full scan
mode, positive ionization mode, with a range of 200–2800 m/z.
For validation of the ligand ﬁshing assay, samples with the re-
ference peptide mixture (bradykinin, angiotensin-II, mambalgin-1,
fasciculin-II, cardiotoxin and α-bungarotoxin), and snake venom (Naja
pallida) spiked with fasciculin-II, were analyzed using the following LC
conditions: gradient elution at 0.50 μL/min with solvent A and B in-
creasing from 1 to 50% solvent B over 110min; an increase to 90%
solvent B over 1min, then isocratic elution at 90% solvent B for 8min.
The injection volume was 1.0 μL and, the concentration and clean-up of
the sample was performed for 4min on the nano-trap column at 10 μL/
min. Note that the α-bungarotoxin sample (Sigma-Aldrich, B137) was a
mixture of two isoforms, while the cardiotoxin sample (Sigma-Aldrich,
C9759) comprised at least seven cardiotoxins.
The LC conditions used to analyze the snake venom samples ob-
tained from the ligand-ﬁshing assays were: isocratic elution at 0.50 μL/
min with 1% of solvent B from 0 to 10min; step gradient elution with
solvent A and B varying from 1 to 35% solvent B from 10 to 20min; an
increase to 65% solvent B in 60min and then to 85% solvent B in
10min; from 90 to 100min the concentration of solvent B was kept at
85%. Prior to the LC separation, for an injection volume of 1.0 μL, pre-
concentration and clean-up of the samples was performed on the nano-
trap column during 4min at 10 μL/min.
The LC conditions used for analyzing the trypsin-digested samples
were as follows: isocratic elution at 0.50 μL/min with 1% of solvent B
from 0 to 10min; gradient elution with solvent A and B varying from 1
to 55% solvent B from 10 to 50 min; an increase to 85% solvent B in
1 min; from 51 to 55 min the concentration of solvent B was kept at
85% and went then back to 1% in 1 min followed by 10 min at this
percentage. The proteomics data generated were analyzed using the
Swissprot_2016 database. Searches included charge states of +1, +2
and + 3. MS tolerance was set at 0.05 Da with an MS/MS tolerance of
0.05 Da. The enzyme used for digestion was trypsin and the global
modiﬁcation set was carbamidomethyl.
2.4. Preparation of eelAChE-modiﬁed magnetic beads
In accordance with a previous report (Vanzolini et al., 2013),
amine-containing- amino-acid residues of eelAChE (0.4mg/mL) were
covalently linked to the surface of modiﬁed magnetic beads (500 μL of a
suspension of 50mg/mL) by the production of an imine group using
glutaraldehyde as linker. After the enzyme immobilization, the pro-
duced imine groups were reduced and the non-reacted aldehyde groups
were end-capped. Using a magnetic separator (BcMag™ magnetic se-
parator-6, Bioclone), the supernatant was discarded from the magnetic
beads and, after which 1.0 mL of a solution containing a mixture of
sodium cyanoborohydride (5.0 mg/mL) and hydroxylamine (3.3 mg/
mL) prepared in phosphate buﬀer (100mM, pH 7.0) was added to the
beads. The reaction was stirred (at 9.0 rpm in an orbital shaker) for
24 h at 4 °C. Then, the prepared eelAChE-MB was washed three times
with 600 μL of Tris-HCl buﬀer (100mM, pH 8) and kept in the same
buﬀer (600 μL). Aliquots of 30 μL were transferred to microcentrifuge
tubes. 30 μL of Tris-HCl buﬀer (100mM, pH 8) was added to each ali-
quot, then they were stored at 4 °C until use. Using the same procedure,
control-MBs were prepared by replacing the enzyme solution with
phosphate buﬀer (100mM, pH 7.0).
2.5. Ligand-ﬁshing assay: small molecules binder versus peptides binder
Contrary to the ligand ﬁshing method developed for small mole-
cules (like tacrine and galantamine) (Vanzolini et al., 2013, 2015), re-
using the eelAChE-MBs for the ligand-ﬁshing assay gave non-re-
producible results with the venoms. One reason may be a change in the
enzyme's conformation or denaturation of a percentage of the enzyme
during the extraction step, in which the pH of the modiﬁed protocol
was decreased to 3.5. Additionally, propidium iodide was used in the
extraction solution in order to displace fasciculin-II from the allosteric
site. Note that in the extraction step used in the method developed for
small molecules, a pH value of 8.0 was used, and this rendered the
enzyme fully active after extraction. Hence, in the case of the method
for small molecules, the eelAChE-MBs can be re-used for multiple li-
gand-ﬁshing experiments. These conditions did not result in detection
of fasciculin-II. Adding methanol to the extraction solution also did not
result in detection of fasciculin-II, probably due to precipitation of
fasciculin-II. As the eelAChE-MBs for venom ligand-ﬁshing could not be
re-used, the original assay volume of 500 μL was decreased to 30 μL
thereby reducing the number of beads used per ligand-ﬁshing assay by
a factor of 16. Additionally, this step signiﬁcantly reduced the volume
needed of small and precious venom samples. As ligand-ﬁshed venom
extracts were analyzed in the current method using nanoLC (the ligand-
ﬁshing method for small molecules uses normal bore LC), this reduction
in assay volume is acceptable as only 1 μL of sample is required for
nanoLC-MS identiﬁcation of ligands.
2.6. Ligand ﬁshing assay with reference peptide mixtures
An eelAChE ligand-ﬁshing assay for venom screening was performed
with a reference peptide mixture containing the AChE peptide binder
fasciculin-II (1.4 μg/mL), and the assumed non-binders mambalgin-1
(5.0 μg/mL), angiotensin-II (0.10 μg/mL), cardiotoxin (25 μg/mL) and
α-bungarotoxin (25 μg/mL) in ammonium acetate (AE) solution
(15mM, pH 8).
In the assay developed, one microcentrifuge tube containing 30 μL
of the prepared eelAChE-MBs was used. Brieﬂy, the eelAChE-MBs were
washed three times with 100 μL of AE solution, and the supernatants
discarded. The eelAChE-MBs were then suspended in 100 μL of the re-
ference peptide mixture. Each tube was then gently stirred in a Biosan®
shaker for 30min at 4 °C and then placed into a magnetic separator
(DiaMag™ magnetic rack, Diagenode) for 120 s. The supernatant (SAChE-
MB-1) was collected and the eelAChE-MBs were washed twice with
100 μL of AE solution by manual shaking for 10 s followed by placing
tubes into the magnetic separator for 120 s. The eelAChE-MBs were then
re-suspended in the extraction solution, 200 μM propidium iodide
prepared in AE buﬀer (15mM, pH 3.5), and gently stirred with a
Biosan® shaker, at room temperature, for 15min. After placement in the
magnetic separator DiaMag™ for 120 s, the supernatant (SAChE-MB-3)
was collected and the eelAChE-MBs were washed twice with 100 μL of
ammonium acetate (15mM, pH 8) by manual shaking for 10 s followed
by placing the tube into the magnetic separator for 120 s; the pooled
supernatant collected after the wash steps was retained for further
analyses. To maintain a similar pH in all samples, 1.0 μL of formic acid
30% (v/v) was added to 90 μL of the supernatants SAChE-MB-1 and SAChE-
MB-3.
Aliquots of 40 μL of SAChE-MB-1 and SAChE-MB-3 were transferred to
LC vials containing inserts of 200 μL. A volume of 1.0 μL was injected in
the nanoLC-MS system for analysis.
The protonated molecular ion [M + xH]x+ used to identify each of
the tested peptides was determined based on the most abundant charge
state: [M+3H]3+ 354.1974 m/z (bradykinin); [M+3H]3+
349.5216m/z (angiotensin-II); [M+11H]11+ 596.8250m/z (mam-
balgin-1); [M+10H]10+ 675.9123m/z (fasciculin-II); two peptides for
α-bungarotoxin (which was a mixture of two isoforms): [M+11H]11+
726.7992m/z and 729.3483 m/z, and seven peptides for cardiotoxin
(which was a mixture of at least seven isoforms): [M+11H]11+
660.1296m/z, 618.4101 m/z, 610.8623m/z, 620.7744m/z,
642.0534m/z, 627.0529 m/z, 622.5068m/z.
For plotting the ligand-ﬁshing assay results, an area for each peptide
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present in SAChE-MB-1 and SAChE-MB-3 was calculated using the software
Data Analysis (Bruker Daltonics®). Together with each experiment, a
control experiment was carried out using the control-MBs for which the
supernatants Scontrol-MB-1 and Scontrol-MB-3 were collected and analyzed
using the same conditions.
To evaluate and validate the applicability of the ligand ﬁshing assay
for snake venoms, and the suitable concentration range of crude venom
to be used, the methodology was applied to Naja pallida venom at three
concentrations (10, 50, 500 μg/mL) spiked with fasciculin-II at 1, 10
and 100 μg/mL, and un-spiked, in a matrix fashion. The ligand ﬁshing
assay was then performed in duplicate for each condition (i.e. for each
concentration of venom and fasciculin tested) using the eelAChE-MBs
and the control-MBs. The results were plotted using the areas found for
the fasciculin-II ion ([M+10H]10+ 675.9123m/z) in the supernatants
SAChE-MB-3 and Scontrol-MB-3.
2.7. Application of the ligand ﬁshing assay for snake venom screening
The validated screening assay was applied to the venom of the
following snake species: Dendroaspis polylepis, D. jamesoni, D. viridis,
Vipera ammodytes, Crotalus basiliscus, Aspidelaps scutatus scutatus and
Micrurus nigrocinctus. All venom samples were prepared as 50 μg/mL
solutions in AE solution (15mM, pH 8). The ligand ﬁshing assays were
performed six times for the mamba venoms (Dendroaspis spp.) and in
duplicate for the others.
The areas (measured as peak area of extracted ion chromatograms
(EICs) from the highest m/z value observed for each peptide) for the
peptides present in SAChE-MB-3 and Scontrol-MB-3 were calculated and
plotted as an aﬃnity ratio:
=
− −
−
−
Affinity ratio Compound area present in S
3/Compound area present in S 3.
AChE MB
control AChE
2.8. Ellman's assay for AChE activity
eelAChE enzymatic activity based on substrate conversion was
measured using an adapted version of Ellman's assay. 10 μL of either
buﬀer (0.1 M potassium phosphate, pH 7.5), or test reagent were added
to individual wells of clear polystyrene 384 well plates (Nunc MaxiSorp,
Thermo-Fisher, U.K.). Unless stated otherwise, all test reagent con-
centrations were prepared as 1:3 serial dilutions from 20 μM, (i.e.
6.6 μM, 2.2 μM, 0.7 μM, 0.2 μM, 823 nM, 274 nM or 91 nM). To each
well, 25 μl of eelAChE (0.03 U/ml) was added and incubated at room
temperature for 45min. After incubation, 50 μl of substrate buﬀer
(2.5 mM [5,5-dithio-bis-(2-nitrobenzoic acid)], 0.4 mM acetylthiocho-
line iodide) was added using a Multidrop 384 Reagent Dispenser
(Thermo-Fisher, the Netherlands). Immediately following substrate
addition, absorbance (405 nm) was measured every ﬁve minutes for a
period of 13 cycles (1 h) at 25 °C using a FLUROstar Omega microplate
reader (BMG Biotech, U.K.). All experiments were performed in tripli-
cate. For data analysis, means of replicates were baseline adjusted and
normalized against eelAChE activity without additive (100% activity).
IC50 and EC50 curves were generated in GraphPad Prism 7.
3. Results and discussion
3.1. Ligand ﬁshing assay validation
A ligand-ﬁshing assay for AChE was reported previously with a
focus on screening mixtures containing small organic molecules
(Vanzolini et al., 2013). The current study describes the development of
a new assay format suitable for screening complex peptide and protein
mixtures, including venoms. We demonstrate that screening venom
mixtures requires a fundamentally diﬀerent assay approach in which
the potential denaturation of peptides and proteins is taken into
account, as well as the highly active and stable proteases present in
many snake venoms. In short, the principal characteristics of animal
venom as matrix requires signiﬁcant adaptations and modiﬁcations
compared to the method developed for screening small molecules.
A typical ligand-ﬁshing assay for discovering small molecular li-
gands is based on four principal steps: matrix load, wash of non/low-
binders, extraction of binders, and a ﬁnal wash/equilibration step to
prepare the immobilized MBs for the next assay. Compared to the re-
ported protocol (Vanzolini et al., 2015), some modiﬁcations were
considered when taking the peptides and proteins present in venoms
into account; the main reason is the precipitation and/or denaturation
of peptides/proteins in the presence of high concentrations of organic
modiﬁers. Based on this, the extraction step in the previously reported
protocol (Vanzolini et al., 2015) was modiﬁed from a small percentage
of organic solvent to a pH decrease. Also, to avoid the potential action
of venom proteases cleaving the immobilized eelAChE enzyme, re-
sulting in inactivation, the load step was tested at 10min and at
30min at two diﬀerent temperatures, 4 °C and room temperature. The
rationale behind this strategy is that reducing incubation temperature
will considerably decrease enzymatic activity, but is likely to inﬂuence
binding to a lesser extent. Secondly, as binding events (association
constants) are usually in the order of seconds (small molecules) to
minutes (peptide/protein binders) and enzymatic reactions from venom
proteases require time to potentially digest the immobilized eelAChE,
shorter incubation times favor binding vs. undesired eelAChE digestion
by venom enzymes.
The reference peptide mixture prepared for the development and
validation of the ligand-ﬁshing assay contained peptides with masses in
a range of 1–7 kDa. It included the venom peptides mambalgin-1, an-
giotensin-II, cardiotoxin and α-bungarotoxin, and the known AChE
binder fasciculin-II used to verify the assay applicability for peptide/
protein mixture screening. The reference AChE binder fasciculin-II is a
three-ﬁnger toxin (3FTx) and is an example of the family of fasciculin
peptides extracted from the venom of Dendroaspis angusticeps that ex-
hibit high aﬃnity for AChE (Radic et al., 1994).
The developed ligand-ﬁshing assay as described in the experimental
section was ﬁrst applied to the reference peptide mixture. The results
obtained are summarized in the graph presented in Fig. 1. As expected,
fasciculin-II was present in a signiﬁcantly higher amount in SAChE-MB-3
(supernatant of the extraction step) than in SAChE-MB-1 (supernatant of
the load step) (measured as the peak areas of the EICs from the highest
m/z value observed), demonstrating that fasciculin-II had aﬃnity for
the immobilized eelAChE enzyme. Furthermore, the non-binders (bra-
dykinin, mambalgin-1 and cardiotoxin) were present in similar
amounts in both SAChE-MB-3 and in Scontrol-AChE-3, which is indicative of
non-speciﬁc interactions with the beads and not with the eelAChE en-
zyme. Angiotensin and α-bungarotoxin were found with a higher area
in SAChE-MB-1 than in SAChE-MB-3, demonstrating that they remain in
solution without signiﬁcant binding to the enzyme, as expected for
these non-binders.
For cardiotoxin and bungarotoxin, multiple ions are plotted as the
commercially available products used consisted of a mixture of dif-
ferent cardiotoxins (CardTx-1 to CardTx-7) (Otvos et al., 2013) and
bungarotoxins (alpha-BuTx-1 and alpha-BuTx-2) (Heus et al., 2013).
After method optimization and evaluation with the peptide re-
ference mixture, the ligand ﬁshing assay validation was performed
using Naja pallida venom at 10, 50 and 500 μg/mL spiked with fasci-
culin-II at 1, 10 and 100 μg/mL, in a matrix fashion. The results are
presented in Fig. 2, where the fasciculin-II area ratio SAChE-MB-3/Scontrol-
AChE-3 was plotted. The measured ratios were signiﬁcantly higher than
1.0 in all cases, demonstrating that the eelAChE aﬃnity ligand ﬁshing of
fasciculin-II was successful for all concentrations of fasciculin-II spiked
in all snake venom concentrations tested. The lower fasciculin-II area
ratio at 500 μg/mL is probably caused by ion suppression during ESI
when analyzing the venom at this high concentration. In general, it is
expected that a high aﬃnity ratio from low or medium intensity signals
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in MS is indicative for a binding interaction. A medium or around the
threshold aﬃnity ratio (SAChE-MB-3/Scontrol-AChE-3= 1.0), in combina-
tion with a high signal in MS, indicates a high concentration of a pro-
tein and thus can indicate a low aﬃnity binder and/or signiﬁcant non-
speciﬁc binding.
3.2. Screening of snake venoms for eelAChE inhibiting peptides and proteins
The assay was then applied to screening several snake venoms in-
cluding those from the western green mamba (D. viridis), Jameson's
mamba (D. jamesoni) and black mamba (D. polylepis). We chose these
venoms since the closely related eastern green mamba (D. angusticeps) is
an abundant source of AChE binding fasciculins (Koh et al., 2006;
Laustsen et al., 2015; Rodriguez-Ithurralde et al., 1983; Viljoen and
Dawie, 1973). Four other snake venoms from the families Elapidae and
Viperidae (Aspidelaps scutatus scutatus, Micrurus nigrocinctus, Crotalus
basiliscus and Vipera ammodytes) were selected as likely ‘negative con-
trols’, as no literature reported toxins in these venoms that bind AChE.
Results from the negative control snake venoms are presented in
Fig. 3 in which a threshold equal to 2.5 for the compound aﬃnity ratio
value (SAChE-MB-3/Scontrol-AChE-3) was selected based on the most intense
aﬃnity ratio value. Compounds below this ratio are considered as non-
speciﬁc or exhibiting very low aﬃnity interactions. Proteins and pep-
tides with ratios above the threshold were deemed to be potential
speciﬁc binders to the immobilized eelAChE target. We applied
statistical calculations (using Prism 7.0 for Mac) to validate this ap-
proach, by applying multiple t-test comparisons (corrected for multiple
comparisons using the Holm-Sidak method) to compare the signals
from the S-3 fractions of the AChE-beads against their respective data
from the S-3 beads without AChE (controls). Signiﬁcance levels were set
to P < 0.01 (**) and P < 0.05 (*) as indicated in Fig. 3.
Ligand ﬁshing assays with venom from Micrurus nigrocinctus re-
vealed one peptide with an aﬃnity ratio close to the threshold (Fig. 3),
which we consider to be a low aﬃnity binder, or a binder with low
abundance in the venom with good ionization eﬃciency in the ESI-MS.
No peptides with aﬃnity ratios above the threshold were detected in
the remaining negative control snake venoms (Fig. 3), although venom
from Crotalus basiliscus contained several small molecular weight
compounds that were detected in the measurements of the supernatant
SAChE-MB-3, albeit with aﬃnity ratios below the described aﬃnity
threshold (Fig. 3).
In the mamba venoms, four peptides yielded aﬃnity ratios higher
than the threshold ratio of 2.5; two had ratios of∼2.8, one of∼5, and
one of∼15. The two peptides with aﬃnity ratios of∼2.8 were from D.
viridis ([M+11H]11+, 683.8821m/z) and D. jamesoni ([M+11H]11+,
672.4984m/z). The peptide with a ratio of∼5 was also ﬁshed from D.
jamesoni venom ([M+11H]11+, 664.4489m/z). Finally, the peptide
with a ratio of ∼15, substantially higher than any other peptide de-
tected in our experiments, was from D. polylepis venom ([M+9H]9+,
721.5765m/z) (Fig. 3).
Fig. 1. Results of the ligand-ﬁshing assay performed with the peptide reference mixture. The areas of the following protonated molecular ions were used to plot the
graph: [M+3H]3+ 354.1974 m/z (bradykinin); [M+3H]3+ 349.5216 m/z (angiotensin-II); [M+11H]11+ 596.8250 m/z (mambalgin-1); [M+10H]10+
675.9123 m/z (fasciculin-II); α-bungarotoxin (alpha-BuTx)-1 [M+11H]11+ 726.7992 m/z, alpha-BuTx-2729.3483 m/z, cardiotoxin (CardTx)-1 [M+11H]11+
660.1296m/z, CardTx-2618.4101 m/z, CardTx-3610.8623 m/z, CardTx-4620.7744 m/z, CardTx-5642.0534m/z, CardTx-6627.0529m/z, CardTx-7622.5068 m/z.
Fig. 2. Results of the ligand-ﬁshing assay performed with Naja pallida venom at 10.0, 50.0 and 500 μg/mL spiked with fasciculin-II at 1.00, 10.0 and 100 μg/mL The
area ratio of the fasciculin-II ion ([M+10H]10+, 675.9123m/z) measured in the supernatants SAChE-MB-3 and in Scontrol-MB-3 is depicted. As the ratios of the extracts
of the AChE-MB experiments vs. the control-MB experiments are plotted, higher fasciculin-II concentrations give lower ratios due to more non-speciﬁc binding at
higher concentrations of fasciculin-II.
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Average masses determined from deconvoluted mass spectra from
the ﬁshed peptides were determined to be 6485.15 Da (ratio ∼2.8, D.
viridis), 7386.42 Da (ratio∼2.8, D, jamesoni), 6634.45 Da (ratio∼5, D.
jamesoni) and 7511.48 Da (ratio ∼15, D. polylepis). The only known
AChE binding proteins isolated from mamba venoms have molecular
masses of 6817.84 Da (fasciculin-I) and 6768.77 Da (fasciculin-II) (Le
Du et al., 1992). Thus, the detected compounds appear to be novel
AChE binding peptides. The measured masses of these peptides suggest
that they might be three-ﬁnger toxins (3FTx; typical mass range
5–10 kDa) or dendrotoxins (typical mass range 6–7 kDa).
Despite being previously isolated from D. polylepis (Joubert and
Taljaard, 1978) and D. viridis (Marchot et al., 1993), no fasciculins were
recovered from any mamba venoms subjected to the ligand ﬁshing
assay. Previous proteomic analysis of mamba venom (from the same
individuals whose venoms were used in this study) (Ainsworth et al.,
2017; Petras et al., 2016) detected the presence of only very small
amounts of fasciculin in D. polylepis venom (<1% total venom content)
and none in D. viridis or D. jamesoni. Additional experiments were
performed to conﬁrm the absence of fasciculin in the D. viridis venom
used for ligand ﬁshing assays. D. viridis venom was spiked with three
diﬀerent concentrations of fasciculin-II (1, 10 and 100 μg/mL) and
analyzed in two diﬀerent ways. Firstly, the spiked samples and a non-
spiked venom sample were analyzed for identiﬁcation of fasciculin-II.
In the spiked venoms, XICs of the most abundant m/z matched that of
fasciculin-II, clearly demonstrating recovery of fasiciulin-II in all con-
centrations spiked, including that of the lowest concentration tested
(1 μg/mL). In the control, non-spiked venom, no fasciculin-II was de-
tected. Secondly, the same venom samples were digested by trypsin
followed by nanoLC-MS/MS analysis. Subsequent Mascot database
searching identiﬁed fasciculin-II in all the spiked venoms. In the non-
spiked samples, no fasciculin was identiﬁed. From this data, it was
concluded that the particular mamba venoms analyzed either did not
contain fasciculin, or they were present at a concentration too low to be
detected using the analytical equipment and methodology presented in
this study.
3.3. Identiﬁcation of AChE binding peptides
The average mass calculated from the deconvoluted mass spectra
(7511.48 Da) of the peptide from D. polylepis with very high binding
aﬃnity ratio (∼15) suggests that it might belong to the 3FTx or den-
drotoxin families. To positively identify the unknown AChE binding
peptide, the D. polylepis SAChE-MB-3 ligand-ﬁshed supernatant was di-
gested with trypsin followed by nanoLC-MS/MS analysis. Subsequent
Mascot searching using the SwissProt database with reptiles set as
taxonomy returned dendrotoxin-I (P00979) from D. polylepis as the top
hit, with a protein score of 891.71 (digest matches) and a sequence
coverage of 63.3%.
The mamba genus-speciﬁc dendrotoxins are a family of neurotoxins
that enhance the release of ACh into the synaptic cleft, through high
aﬃnity blockage of pre-synaptic voltage-gated K+ channels (Harvey,
2001). To our knowledge, dendrotoxin-I has not been described pre-
viously as being able to bind AChE. It is interesting to note that den-
drotoxin-I is the major component of D. polylepis venom, comprising
24% of total venom protein content (Ainsworth et al., 2017; Petras
et al., 2016). The relative abundance of dendrotoxin-I in D. polylepis
venom may explain the high binding ratio in the ligand ﬁshing ex-
periments (Fig. 3), compared to the other members of the genus tested,
whose venom proﬁles are divergent to that of D. polylepis and exhibit
3FTx dominated venom proﬁles with relatively small quantities
(3.4%–16.3% total toxin content) of dendrotoxins (Ainsworth et al.,
2017).
3.4. Dendrotoxins stabilize eelAChE activity in vitro
The biological activity of dendrotoxin-I and the D. angusticeps
homolog, α-dendrotoxin, binding to eelAChE was investigated using an
adapted Ellman's assay for measuring AChE enzymatic activity based on
substrate conversion (Fig. 4). In agreement with previous observations
(Gonicnik and Stojan, 2002), analysis of eelAChE activity without the
addition of additives demonstrates a gradual reduction in the rate of
substrate conversion from approximately 15min onwards throughout
the course of the experiment. Experiments in which eelAChE was pre-
incubated with either dendrotoxin-I or α-dendrotoxin did not demon-
strate similar reductions in the rate of substrate conversion, with the
rate of conversion appearing constant throughout the experiment.
These results suggest that dendrotoxin-I and α-dendrotoxin stabilize
eelAChE over time (Fig. 4a). At 60min, stabilization of eelAChE with
both dendrotoxins resulted in an apparent ∼40% increase in eelAChE
activity (dendrotoxin-I EC50=3.97 μM, α-dendrotoxin
EC50= 1.62 μM) (Fig. 4b) as compared to eelAChE alone. In order to
investigate if potential non-speciﬁc binding of other proteins can result
in any stabilization eﬀect on eelAChE, several proteins were tested in
the assay in combination with eelAChE, including BSA, HSA,
Fig. 3. Aﬃnity ratio values calculated for an accurate mass of each peptide (or small molecular weight compounds in the case of Crotalus basiliscus) identiﬁed in
SAChE-MB-3 of the ligand-ﬁshing assays performed with the snake venoms. The peptides are indicated with one m/z value per peptide (the most intense charge state for
each peptide observed) used to plot extracted ion current chromatograms (XICs) for both supernatant SAChE-MB-3 and Scontrol-MB-3 in order to calculate the compound
peak areas from these sets of two EICs. The charge state of each ion used for analysis is indicated (in parentheses) for each compound. ** (P < 0.01) and *
(P < 0.05) indicate signiﬁcant diﬀerences for t-test comparisons of the signals from the S-3 fractions of the AChE-beads vs. the respective data from the S-3 beads
without AChE (controls).
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myoglobin, and ELISA Blocking reagent (up to 1mg/mL). No stabili-
zation eﬀect was observed in any of these experiments.
Repeating the assay in absence of eelAChE with dendrotoxins pre-
sent at the highest concentrations tested did not result in any substrate
conversion, demonstrating that neither dendrotoxin-I or α-dendrotoxin
have any enzymatic activity towards the substrate (Fig. 4c). Further
experiments suggest other dendrotoxin homologs, such as dendrotoxin-
K and σ-dendrotoxin have similar eelAChE stabilizing properties
(Supplemental Fig. 1), indicating this activity may be an inherent at-
tribute of dendrotoxins. Additional experiments in which α-den-
drotoxin was incubated at 10 μM tested in combination with AChE in-
hibitors fasciculin-II or tacrine, at their full inhibitory concentrations,
resulted in no detected eelAChE activity (Supplemental Fig. 2), sug-
gesting α-dendrotoxin binds to eelAChE in an allosteric manner. Further
investigations will be required to determine if the observed activities
are similar in mammalian AChE and to deduce any biological sig-
niﬁcance in envenoming. Regardless of any physiological eﬀect, this
ﬁnding may be useful to stabilize AChE in biotechnological applica-
tions.
4. Conclusions
A variety of approaches have previously been described to identify
AChE inhibitors in natural or synthetic libraries (Miao et al., 2010). The
vast majority of such approaches are based on colorimetric methods
using Ellman's reagent or Fast Blue B salt reagent, with solution based
enzyme assays (Di Giovanni et al., 2008). The aﬃnity-based screening
assay reported herein is a label-free assay, where the ligand-ﬁshing
technique was used for the ﬁrst time to identify AChE ligands in com-
plex peptide/protein mixtures. For analysis of venoms, the assay had to
be modiﬁed signiﬁcantly compared to the published method for
screening a compound synthetic library (Vanzolini et al., 2015). For
example, the paramagnetic beads used for ligand ﬁshing can be used
only once and covalent eelAChE immobilization was required to prevent
release of eelAChE from the beads during ligand extraction under low
pH conditions. After method development, we demonstrated the ap-
plicability of the method to screening venoms. We identiﬁed den-
drotoxin-I from black mamba venom as a high-aﬃnity eelAChE binder,
an activity not previously associated with this class of toxins. Further
experiments demonstrated that both dendrotoxin-I and α-dendrotoxin
stabilize, thereby enhancing, eelAChE activity in vitro.
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